A strategy to design protein-based antagonists against type I cytokine receptors. - Ullrich T; Klimenkova O; Pollmann C; Lasram A; Hatskovska V; Maksymenko K; Milijaš-Jotić M; Schenk L; Lengerke C; Hartmann MD; Piehler J; Skokowa J; et al. (PLoS biology, 2024)